Cancer
Showing of 91 results
University Hospitals Seidman Cancer Center researchers Demonstrate Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation
Lead author, Dr. Angela Jia, MD, PhD, presented randomized Phase III results at ASTRO 2026.
University Hospitals Seidman Cancer Center hosts first international pre-launch event for Siemens Healthineers new Accela
University Hospitals Seidman Cancer Center hosted a contingent of international journalists, along with Siemens Healthineers, for the first pre-launch event for the highly anticipated Accela.
University Hospitals researchers find major increase in the use of MRI before prostate biopsy
Results published in JAMA Oncology.
Scientists Turn COVID-19 Immune Memory into a Powerful New Ally Against Cancer
Celloram, Inc., University Hospitals and Case Western Reserve University unveil PROTEXI, a novel cancer vaccine platform advancing toward first-in-human clinical trials in sarcoma patients.
Insurance-Supported Integrative Oncology Program Improves Patients’ Symptoms
New Study Published in JCO Oncology Practice.
Harrington Discovery Institute Researchers Identify New Drug Targets for Hard-to-Treat Cancers
New study of human cancers published in Science Signaling.
Dee and Jimmy Haslam Make $12.5 Million Transformational Investment in Blood Cancer Research and Treatments at University Hospitals
Benefiting patients worldwide, funding accelerates chronic lymphocytic leukemia research and rare cancer drug development through the Oxford-Harrington Rare Disease Centre and UH Seidman Cancer Center.
UH Seidman Cancer Center researchers to test a gut microbiome intervention as part of a cancer therapy regimen
The S2419 BioFront study is chaired by medical oncologist and Miggo Family Chair in Cancer Research, Pedro Barata, MD, M.Sc.